Cargando…

The influence of Apolipoprotein E genotype on regional pathology in Alzheimer’s disease

BACKGROUND: Carriers of the ApoE ϵ4 allele are at a greater risk for developing Alzheimer’s disease (AD) and those who do develop AD tend to have a much greater neuropathological disease burden. Although several studies have shown significant differences in AD pathology among ϵ4 carriers and non-car...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sabbagh, Marwan N, Malek-Ahmadi, Michael, Dugger, Brittany N, Lee, Katarina, Sue, Lucia I, Serrano, Geidy, Walker, Douglas G, Davis, Kathryn, Jacobson, Sandra A, Beach, Thomas G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654892/ https://www.ncbi.nlm.nih.gov/pubmed/23663404 http://dx.doi.org/10.1186/1471-2377-13-44

Ejemplares similares

Impaired hepatic amyloid-beta degradation in Alzheimer’s disease
por: Maarouf, Chera L., et al.
Publicado: (2018)

Quantitative Appraisal of Ventricular Cerebrospinal Fluid Biomarkers in Neuropathologically Diagnosed Parkinson’s Disease Cases Lacking Alzheimer’s Disease Pathology
por: Maarouf, Chera L., et al.
Publicado: (2013)

Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment
por: Dugger, Brittany N., et al.
Publicado: (2015)

TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post‐Mortem Temporal Cortices
por: Lue, Lih‐Fen, et al.
Publicado: (2014)

Morphological and Pathological Evolution of the Brain Microcirculation in Aging and Alzheimer’s Disease
por: Hunter, Jesse M., et al.
Publicado: (2012)

Sensitivity to change and prediction of global change for the Alzheimer’s Questionnaire
por: Malek-Ahmadi, Michael, et al.
Publicado: (2015)

Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
por: Decourt, Boris, et al.
Publicado: (2013)

Biochemical Assessment of Precuneus and Posterior Cingulate Gyrus in the Context of Brain Aging and Alzheimer’s Disease
por: Maarouf, Chera L., et al.
Publicado: (2014)

Improved diagnosis of Parkinson's disease from a detailed olfactory phenotype
por: Gerkin, Richard C., et al.
Publicado: (2017)

Informant-reported cognitive symptoms that predict amnestic mild cognitive impairment
por: Malek-Ahmadi, Michael, et al.
Publicado: (2012)

Reduced clinical and postmortem measures of cardiac pathology in subjects with advanced Alzheimer's Disease
por: Beach, Thomas G, et al.
Publicado: (2011)

The role of sex differences in depression in pathologically defined Alzheimer’s disease
por: Tremblay, Cécilia, et al.
Publicado: (2023)

Inflammation and the pathological progression of Alzheimer’s disease are associated with low circulating choline levels
por: Judd, Jessica M., et al.
Publicado: (2023)

KIF6 719Arg Carrier Status Association with Homocysteine and C-Reactive Protein in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Patients
por: Malek-Ahmadi, Michael, et al.
Publicado: (2013)

Differences in Cerebrospinal Fluid Biomarkers between Clinically Diagnosed Idiopathic Normal Pressure Hydrocephalus and Alzheimer’s Disease
por: Tsai, Andrew, et al.
Publicado: (2014)

Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer’s disease and aged brains: increased levels correlate with neuropathology
por: Mendsaikhan, Anarmaa, et al.
Publicado: (2019)

Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition
por: Filon, Jessica R., et al.
Publicado: (2016)

Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer’s Disease Brains
por: Walker, Douglas G., et al.
Publicado: (2020)

Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging
por: Maarouf, Chera L., et al.
Publicado: (2011)

Cerebral blood flow in Alzheimer’s disease
por: Roher, Alex E, et al.
Publicado: (2012)

Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease
por: Malek-Ahmadi, Michael, et al.
Publicado: (2019)

Advances in Deep Neuropathological Phenotyping of Alzheimer Disease: Past, Present, and Future
por: Shakir, Mustafa N, et al.
Publicado: (2022)

Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases
por: Walker, Douglas G., et al.
Publicado: (2016)

Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer’s dementia?
por: Crum, Jana, et al.
Publicado: (2018)

Is diabetes associated with increased pathological burden in Alzheimer's disease?
por: Sadrolashrafi, Kaviyon, et al.
Publicado: (2021)

Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline
por: Tang, Ziqi, et al.
Publicado: (2019)

The effects of apolipoprotein E genotype, α-synuclein deficiency, and sex on brain synaptic and Alzheimer's disease–related pathology
por: Bar, Roni, et al.
Publicado: (2017)

Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer’s disease dementia
por: Beach, Thomas G., et al.
Publicado: (2020)

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
por: Sabbagh, Marwan N., et al.
Publicado: (2019)

Editorial Introduction to the Special Issue from the International Symposium on Biomarkers for Alzheimer’s Disease and Related Disorders
por: Sabbagh, Marwan N.
Publicado: (2017)

Mitochondrial DNA Rearrangement Spectrum in Brain Tissue of Alzheimer’s Disease: Analysis of 13 Cases
por: Chen, Yucai, et al.
Publicado: (2016)

Effect of olfactory bulb pathology on olfactory function in normal aging
por: Tremblay, Cécilia, et al.
Publicado: (2022)

Recent Perspectives on APP, Secretases, Endosomal Pathways and How they Influence Alzheimer’s Related Pathological Changes in Down Syndrome
por: DeCourt, Boris, et al.
Publicado: (2013)

Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized Cohort
por: Malek-Ahmadi, Michael, et al.
Publicado: (2013)

Association of serum Apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer’s pathology
por: Hu, Hao, et al.
Publicado: (2020)

Effect of apolipoprotein genotype and educational attainment on cognitive function in autosomal dominant Alzheimer’s disease
por: Langella, Stephanie, et al.
Publicado: (2023)

The blood-brain barrier models to study apolipoprotein E genotypes in Alzheimer's disease
por: Dias, Irundika HK, et al.
Publicado: (2022)

Apolipoprotein E Genotype and Cardiovascular Diseases in the Elderly
por: Haan, Mary N., et al.
Publicado: (2010)

Prevalence of REM sleep behavior disorder in Sun City, Arizona
por: Shprecher, David R., et al.
Publicado: (2020)

Investigational drugs for the treatment of AD: what can we learn from negative trials?
por: Jacobson, Sandra A, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_o8doo8vj7pqqe9b20na5viah52